Fig 1: The clinical significance of five key genes in patients with HCC. (A), RT-qPCR detection of CDC20, TOP2A, RRM2, UBE2C and AOX1 expression in the cancer and adjacent normal tissues from 72 HCC patients. (B), Immunohistochemistry analysis of CDC20, TOP2A, RRM2, UBE2C and AOX1 proteins in the cancer and adjacent normal tissues from 72 HCC patients (400 ×). n = 10. (C), Kaplan-Meier analysis of the relationship between the expression of 5 key genes and the prognosis of 72 patients with HCC. The X-axis represents survival time (months), and the Y-axis represents survival rate. ****p < 0.0001.
Fig 2: Survival analysis and ROC curve of five core genes in TCGA-LIHC cohort. (A), The survival curve of CDC20 in HCC. (B), The survival curve of TOP2A in HCC. (C), The survival curve of RRM in HCC. (D), The survival curve of UBE2C in HCC. (E), The survival curve of AOX1 in HCC. The X-axis indicates survival time (years), and the Y-axis indicates survival rate. p value is shown in the header. Red indicates high gene expression, and blue indicates low gene expression. (F), AUC values of five genes were calculated separately, and ROC curves were drawn. In the figure, the five genes are represented by different colors, and the color code and AUC values are shown at the bottom right.
Supplier Page from Abcam for Anti-Aldehyde Oxidase antibody - C-terminal